StockData
Septerna, Inc. logo

Septerna, Inc. (SEPN) stock

SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30165% above fair value
$40.02−1.65 (-3.96%)

Close on Nov 17, 2026Market cap $1.87BP/E –Yield –

Septerna operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Septerna's operating cash flow for the twelve months ending Sep 30, 2026 was -$76.57M, down 173.5% year over year. For fiscal 2025 it was $110.19M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$110.19M–
FY2024Dec 31, 2024-$67.47M–
FY2023Dec 31, 2023-$38.72M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$13.77M-108.2%
Q2 FY2026Jun 30, 2026-$22.18M–
Q1 FY2026Mar 31, 2026-$25.63M–
Q4 FY2025Dec 31, 2025-$14.99M–
Q3 FY2025Sep 30, 2025$168.81M–
Q2 FY2025Jun 30, 2025-$20.29M–
Q1 FY2025Mar 31, 2025-$23.34M–
Q4 FY2024Dec 31, 2024-$20.96M–
Q3 FY2024Sep 30, 2024-$16.81M–
Q2 FY2024Jun 30, 2024-$12.99M–
Q1 FY2024Mar 31, 2024-$16.71M–
Q4 FY2023Dec 31, 2023-$8.80M–

More Septerna figures

See a number that looks wrong?